Why it's time to treat medicinal cannabis as an alternative therapy, not a pharmaceutical
- Written by Marta Rychert, Senior Researcher in Drug Policy, Massey University
ShutterstockThe recent approval of two domestically produced cannabidiol (CBD) oil products – non-intoxicating cannabis compounds – may have provided new optimism to patients on cannabis prescriptions. Slow progress with product approvals had meant some patients had feared they would need to turn to the black market.
Yet these new...
Read more: Why it's time to treat medicinal cannabis as an alternative therapy, not a pharmaceutical
